Coronavirus drug remdesivir to cost $2,340 per patient in the U.

FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File) .

FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File) .

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.

“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.

“We believe that we had to really deviate from the normal circumstances” and price the drug to ensure wide access rather than based solely on value to patients, he said.

The 250,000 treatment courses that the company had donated to the U.S. and other countries will run out in about a week, and the prices will apply to the drug after that.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

In the U.S., federal health officials have allocated the limited supply to states, but that will end in September.

Trending Stories

  • South Korea has entered its 2nd wave of coronavirus. What can Canada learn?

  • Winnipeg woman shocked after getting ambulance bill for partner shot, killed by police

“We should have sufficient supply … but we have to make sure it’s in the right place at the right time,” O’Day said

In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course.

Remdesivir’s price has been highly anticipated since it became the first medicine to show benefit in the pandemic, which has killed more than half a million people globally in six months.

The drug interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. It had not improved survival according to preliminary results after two weeks of followup; results after four weeks are expected soon.

The Institute for Clinical and Economic Review, a non-profit group that analyzes drug prices, said remdesivir would be cost-effective in a range of $4,580 to $5,080 if it saved lives. But recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between $2,520 and $2,800.

The drug is has emergency use authorization in the U.S. and Gilead has applied for full approval.

© 2020 The Canadian Press

Related news

Polish president elected to 2nd term after harsh campaign.

Duda received 51.03 per cent of Sunday's vote, while Trzaskowski got 48.97 per cent, according to final results Monday from the state electoral commission.

1 3

Kyiv Court Eases Pretrial Restrictions For Suspect In Sheremet's Killing.

A Kyiv court has eased pretrial restrictions for one of the suspects in the high-profile 2016 killing of journalist Pavel Sheremet in the Ukrainian capital.

‘Scariest place on Earth’: Disney World mocked for opening amid virus spike.

Disney World and its eager customers are facing sharp criticism for opening during record-setting coronavirus numbers in Florida.

More than 200 universities back lawsuit over Trump’s international student restrictions.

The schools have signed court briefs supporting Harvard University and the Massachusetts Institute of Technology as they sue U.S. Immigration and Customs Enforcement in federal court in Boston.

Chinese vase found in pet-filled house sells for more than $12M.

The vase had previously sold through the same auction house for $56 and again for $100 in 1954.

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies